title: [Study on orally active cephalosporin pro-drug. Synthesis, oral absorption and antibacterial activity of (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 7-[D-O-(aminoacyl)mandelamido]-3-[[(5-methyl-1,3,4-thiadiazol -2-yl)-thio]methyl]-3-cephem-4-carboxylates].
authors.forename: S
authors.initials: S
authors.lastname: Nishizawa
authors.forename: A
authors.initials: A
authors.lastname: Yoshimi
authors.forename: H
authors.initials: H
authors.lastname: Muro
authors.forename: M
authors.initials: M
authors.lastname: Kasai
authors.forename: S
authors.initials: S
authors.lastname: Hatano
authors.forename: H
authors.initials: H
authors.lastname: Hashizume
authors.forename: T
authors.initials: T
authors.lastname: Yamada
authors.forename: E
authors.initials: E
authors.lastname: Hashimoto
authors.forename: K
authors.initials: K
authors.lastname: Nishimura
authors.forename: N
authors.initials: N
authors.lastname: Kakeya
mesh_terms: D000818:Animals; D002437:Cefazolin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000627:therapeutic use; D002511:Cephalosporins; D007408:Intestinal Absorption; D051379:Mice; D011355:Prodrugs; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013329:Structure-Activity Relationship; D014552:Urinary Tract Infections / Q000188:drug therapy
chemical_list: D002511:Cephalosporins; D011355:Prodrugs; C022605:cefcanel; C045380:cefcanel daloxate; D002437:Cefazolin